← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Susanne Olausson
Styrelseordförande
Profile key: se|susanne olausson
Purchase history
- Companies traded
- 3
- Purchases · 12M
- 1
- Purchases · 24M
- 7
- Average purchase
- SEK 84,472
- Gross purchase value
- SEK 591,303
- Last purchase
- 2026-09-10
- Completed 20D events
- 7.0
- Outcome status
- PASS
Latest company: Redsense Medical AB publ
Companies: Odinwell AB | Redsense Medical AB (publ) | Redsense Medical AB publ
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing | 100.0% (7/7) | 28.6% (2/7) | -6.1% | -3.6% | -7.1% |
| 20D | 7Developing | 100.0% (7/7) | 14.3% (1/7) | -19.3% | -15.8% | -33.4% |
| 60D | 6Developing | 100.0% (6/6) | 0.0% (0/6) | -29.8% | -28.8% | -30.8% |
| 120D | 6Developing | 100.0% (6/6) | 0.0% (0/6) | -49.8% | -50.5% | -57.4% |
Research patterns
- First purchase in 12M
- 0/6
- Large purchase ≥ €100k
- 0/7
- Cluster buying · 15D
- 1/7
- Buying the dip · ≥20% below prior 52W high
- 7/7
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.